Webinar Recordings

Application of TALLman Lettering for Selected High Alert Drugs in Canada

Drug name confusion, particularly because of look-alike, sound-alike (LASA) name attributes can be a contributing factor to medication related adverse events. TALLman lettering is one of many risk mitigation strategies to minimize errors involving LASA drug names. ISMP Canada invites healthcare professionals to participate in a one hour complimentary webinar that will provide an opportunity